Skip to main content

Main menu

  • About
    • Our Mission
    • Donors
    • Board of Directors
    • Advisory Boards
    • Staff
    • Careers
    • FAQ
    • Annual Report
  • Why New TB Drugs?
    • Global Pandemic
    • Inadequate Treatment
    • Antimicrobial Resistance
    • Maternal and Child Health
    • Cycle of Poverty
  • R&D
    • Scientific Vision
    • Pipeline
    • Discovery
    • Engaging Communities
  • Access
    • Our Commitment
    • Access in TB Market
    • Child-friendly medicines
    • Pretomanid and BPaL
    • Pathways to Access BPaL
  • News
    • Latest News
    • Publications
    • Voices of TB
    • Research Papers
    • Making an Impact
  • Donate

Search form

Publications

Keeping The Promise

  • Click here to download the full report

Accessing Improved TB Medicines for Children

  • Click here to download the full report

2021 Annual Report

  • 2021 Annual Report

Other Publications

Global Investments in Tuberculosis Research and Development

  • Click here to download the full report

Falling Short: Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis

  • Click here to download the report

New TB Regimens: What Countries Want

  • Click here to download the report

New Pathways for Childhood TB Treatment

  • Click here to download the full report

Pathway to Patients

Pathway to Patients is the first comprehensive analysis of how today's TB drugs reach patients on a global scale.

  • > Study Overview
  • > Compendium of Findings
  • > Country-specific results

The Economics of TB Drug Development

  • > Executive Summary
  • > Full report

Scientific Blueprint for TB Drug Development

  • > Executive Summary
  • > Full Blueprint

Factsheets & Brochures

Accessing Improved TB Medicines for Children

  • English
  • Français (French)
  • Español (Spanish)
  • русский (Russian)

HIV and Tuberculosis: A Dual Epidemic

  • English

About TB Alliance (Brochure)

  • English
  • Français (French)
  • Español (Spanish)
  • русский (Russian)

New Tools Factsheet

  • English
  • Français (French)
  • Español (Spanish)
  • русский (Russian)

PDP Model Factsheet

  • English
  • Français (French)
  • Español (Spanish)
  • русский (Russian)

Drug-Resistant TB Factsheet

  • English
  • Français (French)
  • Español (Spanish)
  • русский (Russian)

About TB Alliance (Factsheet)

  • English
  • Français (French)
  • Español (Spanish)
  • русский (Russian)

Annual Reports & Statements

TB Alliance 2021 Tax Return

2021 Financial Statement

2021 Annual Report

Charting the Course

2020 TB Alliance Financial Statement

2020 Annual Report

Gaining Ground

2019 TB Alliance Financial Statement

2019 Annual Report

Breaking Through

2018 TB Alliance Financial Statement

2018 Annual Report

A New Frontier

2017 TB Alliance Financial Statement

2017 Annual Report

Turning the Tide

2016 TB Alliance Financial Statement

2016 Annual Report

Making An Impact

2015 TB Alliance Financial Statement

2015 Annual Report

Reaching Further

2014 TB Alliance Financial Statement

2014 Annual Report

What it takes

2013 TB Alliance Financial Statement

2013 Annual Report

Change starts here

2012 TB Alliance Financial Statement

2012 Annual Report

Realizing the Promise

2011 TB Alliance Financial Statement

2011 Annual Report

Crossing Thresholds

2010 TB Alliance Financial Statement

2010 Annual Report

More Than Ever

2009 TB Alliance Financial Statement

2009 Annual Report

Accelerating the Pace

2008 TB Alliance Financial Statement

2008 Annual Report

Combating TB: What it Takes

2007 Annual Report

Advancing the Pathway: Novel approaches to getting faster and better TB drugs to patients

2005/2006 Annual Report

2004/2005 Annual Report

2003/2004 Annual Report

2002/2003 Annual Report

2001/2002 Annual Report

Navigate

  • About
  • Why New TB Drugs?
  • R&D
  • Access
  • News
  • Donate

New York: 80 Pine Street, 20th floor, New York, NY 10005 • +1 212 227 7540

Pretoria: Boardwalk Office Park, Block 1/Suite 5, 107 Haymeadow Street, Faerie Glen, Pretoria 0043, South Africa • +27 12 991 6328

Visit our South Africa website
Press Inquiries

Thomas Lynch
p | +1 646 616 8639
e | thomas.lynch@tballiance.org

Jobs

View job openings

Join our mailing list
Interests
© 2023 The TB Alliance. All Rights Reserved. Site by Darby Communications Report a Concern